<<

WYOMING

PRODUCTS: • precursor products containing , , or liquid products with ephedrine or pseudoephedrine as the sole active ingredient and may be marketed or sold in the US under the FDA as a nonprescription drug. (W.S. 35-7-1059(p) )

SALES LIMITS: • No person shall obtain more than 3.6 grams per calendar day regardless the number of transactions. No person shall obtain more than 9grams of PPA base, of which no more than 7.5 grams can be imported by private or commercial carrier or the US Postal Service during any 30 day period. W.S. 35-7-1059(i)) • Retail sale of PSE, EPH and PPA products limited to 2 packages of a product containing methamphetamine precursor .(W.S. 35-7-1059)

SALES RESTRICTIONS: • Retail sale of nonexempt EPH, PSE and PPA products are restricted to packages containing no more than 3 grams of one or more precursors calculated in terms of active base and in blister packs containing no more than 2 dosage units in each blister… or if blister packs technically infeasible, sales in unit dose packets or pouches. (W.S. 35-7-1059)

PRODUCT PLACEMENT: • Retail distributors must display nonexempt EPH, PSE and PPA products in one of the four following ways: • Behind a store counter in an area not accessible to customers; • In a locked case so that the customer must ask for store employee assistance to purchase; • Displayed within 30 feet of and in direct line of sight of cash register or counter staffed by store employee and store must employ a reliable alarm system to prevent the theft of multiple packages; or • In a location under constant video surveillance where persons removing products are in camera’s view that records recognizable images at least once every 10 seconds, surveillance images are preserved for at least 168 hours and available to law enforcement upon request, and with a sign posted prominently stating that the area is under constant video camera surveillance. (W.S. 35-7-1059)

ELECTRONIC LOGBOOK REQUIREMENT: • Seller shall maintain written or electronic list of methamphetamine sales in a logbook that identifies the product by name, quantity sold, names and addresses of purchasers, and date and time of the sales except that such requirement

doesn’t apply to any purchase by an individual of a single sales package if that package contains not more than 60miligrams of PSE. • Seller shall maintain each entry in the logbook for not fewer than 2years after the date which the entry is made.

LIABILITY: • The regulated seller who in good faith releases logbook information to federal, state or local law enforcement authorities is immune from civil liability for such release unless the release constitutes gross negligence or intentional, wanton, or willful misconduct.

PENALTIES: • Possession of more than 15 grams of EPH, PSE or PPA is prohibited, except that those holding appropriate license / registration from the board of pharmacy including retail distributors, wholesalers, wholesale distributors, manufacturers, pharmacists and practitioners in the course of practice may possess more than 15 grams in the course of legitimate business. Knowing violations of possession restrictions are a felony punishable by imprisonment for up to 15 years, $25,000 fine or both. (W.S. 35-7-1059) • Knowing and intentional violation of sales limits, package size restrictions and placement requirements are a misdemeanor punishable by $100 fine for first offense, $500 fine for second offense within 2 years and $1,000 fine with up to six months imprisonment or both for third offense within a three year period. (W.S. 35-7-1059) • Failure to comply with license requirement, retailer display and sales requirements, and manufacturer / distributor record requirements are punishable by the Board of Pharmacy. The board may revoke, suspend or assess administration penalties for violations up to $100 for the first offense, $500 for the second offense within 2 years and $1,000 for the third offense within 3 years. (W.S. 35-7-1059)

WHOLESALE DISTRIBUTION REQUIREMENTS: • Manufacturers and wholesale distributors must provide monthly reports (by no later than the 10 th of the month for the previous month) including a listing by retail vendor, including the product name, package size, date sipped and quantity shipped. (W.S. 35-7-1059)

OTHER: • All resident and nonresident retailers, manufacturers and distributors of all EPH, PSE and PPA products must obtain a registration from the Board of Pharmacy for each separate facility where distributions are conducted. These establishments are subject to inspection by the board. For retailers, the inspection will focus on method of display and sale of products; for manufacturers and wholesale distributors, the inspection will be of the purchase and sale records. (W.S. 35-7-1059)